Grounding the scientific data into actionable insights for drug sponsors, the 5th NASH Summit is the outstanding forum and unrivalled platform for biotech and pharma to regroup, reassess and realign their NASH pipeline strategy.

Uniting 100+ NASH experts from the EMA, Novartis, Gilead, Pfizer, Eli Lilly, Takeda, AstraZeneca, Merck, Janssen, Ionis, Novo Nordisk, the FDA and more, including stakeholders at the helm of NASH drug development and on the periphery, this industry focused forum is bringing together content perfectly aligned with wherever you sit on prioritising NASH, so you can continue to keep on top of this huge unmet medical need and massive opportunity for drug sponsors to scratch the pad of available, approved, NASH therapeutics.

To know more visit: https://nash-summit.com/